FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development

10 Nov 2022

In this application note, Berkeley Lights presents its Beacon® Optofluidic System for cell line development.

Beacon® Optofluidic System

Bruker Cellular Analysis

With the Beacon system’s light-speed workflows, you’ll gain insights, iterate and innovate. Replace a roomful of equipment with the Beacon system Work fast with individual cells  Perform assays at any time, as often as you need Track phenotype and genotype of single cells or clones Automate and scale workflows beyond manual, time-intensive analysis Generate great insights through deep profiling of each cell or clone

(0)

Links

Tags

FDA-accepted monoclonality assurance on the Beacon Optofluidic System for cell line development